Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon R W Stott

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Parkinson'S Disease|July 20, 2024
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateKevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Alzheimer'S Disease : JAD|December 28, 2017
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down SyndromeRuma Raha-Chowdhury, James W Henderson, Animesh Alexander Raha, et al.
Cell|October 8, 2016
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem CellsGioele La Manno, Daniel Gyllborg, Simone Codeluppi, et al.
Journal of Neurology|February 18, 2026
Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's diseaseMarco Toffoli, Elisa Menozzi, Mairead Cullen, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial PlatformCristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
The New England Journal of Medicine|April 10, 2024
Trial of Lixisenatide in Early Parkinson's DiseaseWassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Parkinson'S Disease|July 20, 2024
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateKevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Alzheimer'S Disease : JAD|December 28, 2017
Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down SyndromeRuma Raha-Chowdhury, James W Henderson, Animesh Alexander Raha, et al.
Cell|October 8, 2016
Molecular Diversity of Midbrain Development in Mouse, Human, and Stem CellsGioele La Manno, Daniel Gyllborg, Simone Codeluppi, et al.
Journal of Neurology|February 18, 2026
Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's diseaseMarco Toffoli, Elisa Menozzi, Mairead Cullen, et al.
Journal of Parkinson'S Disease|April 5, 2024
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials InitiativeRichard K Wyse, Tom Isaacs, Roger A Barker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 18, 2025
Treatment Selection and Prioritization for the EJS ACT-PD MAMS Trial PlatformCristina Gonzalez-Robles, Dilan Athauda, Thomas R Barber, et al.
The New England Journal of Medicine|April 10, 2024
Trial of Lixisenatide in Early Parkinson's DiseaseWassilios G Meissner, Philippe Remy, Caroline Giordana, et al.
Pageof 3